Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
DS89002333
i
Other names:
DS89002333, DS-89002333, DS 89002333
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Daiichi Sankyo
Drug class:
PRKACA inhibitor
‹
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
DNAJB1-PRKACA fusion
Hepatocellular Cancer
DNAJB1-PRKACA fusion
Hepatocellular Cancer
DS89002333
Sensitive: D – Preclinical
DS89002333
Sensitive
:
D
DS89002333
Sensitive: D – Preclinical
DS89002333
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.